A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Medically reviewed by Katlein Franca, MD Eczema is a chronic (long-lasting) inflammatory condition that causes rashes of scaly, irritated, itchy, dry skin. Affected areas can change color and harden.

Eczema is one of those skin conditions that can sneak up on anyone, turning what should be simple daily routines into a bit ...

Best for all ages: Eczema Honey Skin-Soothing Cream. Eczema Honey Skin-Soothing Cream. $29.94 $34.99 at Amazon $29.99 at Target $29.95 at Ulta. What we like. Gentle for daily use; Little goes a ...

Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a ...

Welcome to DM a Derm, where GLAMOUR's resident dermatologists help solve your sk-inquiries. DM us at @glamouruk.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...

Discover life-changing eczema treatments and remedies that provide real relief. From prescription breakthroughs to natural ...

If there is any truth to the nursery rhyme “April showers bring May flowers,” you can get ready for allergy season and eczema ...

Arcutis Biotherapeutics has enrolled the first child in an open-label Phase II trial of Zoryve (roflumilast) for atopic dermatitis.

An irritating skin condition is flaring up for a third of Australians trying to keep warm this winter, made worse by heaters, woollen jumpers and long, hot showers.

The FDA pushed back the Prescription Drug User Fee Act action date for ruxolitinib cream (Opzelura) by three months to September 19, 2025. The extension will allow regulators time to review additional ...